Global Neuroblastoma Clinical Trial Pipeline Highlights - 2021
New Treatment Boosts Survival in Kids with Neuroblastoma - NFCR
Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) | SpringerLink
Current selected clinical trials on NB | Download Table
Frontiers | CAR T Cell Therapy for Neuroblastoma | Immunology
New Treatment for Neuroblastoma Is in Early-Stage Trials
Drugs of clinical trials for HR neuroblastoma interventetion | Download Table
Current epigenetic drugs clinical trials in Neuroblastoma | Download Table
Neuroblastoma Treatment and Clinical Trials
Clinical Trial Enrollment Fairly Robust in Pediatric Neuroblastoma - Physician's Weekly
Doxorubicin for Newly Diagnosed High Risk Neuroblastoma Clinical Trial | Power
First-in-humans clinical trial to treat children with relapsed neuroblastoma opens at American Family Children's Hospital
Results of a prospective clinical trial JN‐L‐10 using image‐defined risk factors to inform surgical decisions for children with low‐risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee -
Too many targets, not enough patients: rethinking neuroblastoma clinical trials | Nature Reviews Cancer
Daily Dose - Neuroblastoma Clinical Trial Gives Two International Patients Another Chance at Life
Cooperative Clinical Trials with 13-Cis-Retinoic Acid in Neuroblastoma Katherine K. Matthay, M.D University of California, San Francisco Children's Oncology. - ppt download
Summary of CAR T cell clinical trials for neuroblastoma. | Download Table
Integrative discovery of treatments for high-risk neuroblastoma | Nature Communications
Intellasia East Asia News - Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma - European Journal
SIOPEN High-Risk Neuroblastoma Clinical Trial 2 to open in the UK in 2021 — Neuroblastoma UK
Grant Round 2021 — Neuroblastoma UK
